Literature DB >> 18073130

Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.

Orlando D Gil1, Catherine Lee, Edgardo V Ariztia, Feng-Qiang Wang, Phillip J Smith, Joanie Mayer Hope, David A Fishman.   

Abstract

OBJECTIVES: To evaluate the role of LPA in regulating E-cadherin cell surface expression, adhesion, and invasion in epithelial ovarian carcinoma (EOC) cells.
METHODS: E-cadherin mRNA expression in OVCA429 and IOSE-29 cells was evaluated by real-time RT-PCR. Immunofluorescence and Western blot analysis were performed to determine cell surface expression and shedding of E-cadherin 80-kDa soluble fragment by LPA. Kinetics of LPA-induced uPA activity was followed with a colorimetric enzymatic assay. Invasion assays were performed in a modified Boyden chamber where cells were allowed to migrate to the bottom compartment through a porous filter coated with collagen. Additionally we measured the 80-kDa form from the ascites of women with stage III/IV EOC.
RESULTS: LPA induces E-cadherin shedding of a soluble 80-kDa fragment. We found that this process is mediated by the uPA proteolytic cascade. High levels of soluble E-cadherin were found in the ascites from women with advanced stage EOC. LPA and a soluble recombinant E-cadherin-Fc chimera promotes invasion of OVCA429 cells.
CONCLUSIONS: LPA induces shedding of an 80-kDa E-cadherin-soluble fragment in an uPA-dependent manner and promotes in vitro invasion. High levels of soluble E-cadherin in malignant ascites may also affect ovarian metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18073130     DOI: 10.1016/j.ygyno.2007.10.027

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  18 in total

1.  Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development.

Authors:  Hui Li; Zhenwen Zhao; Gang Wei; Libo Yan; Dongmei Wang; Hong Zhang; George Earl Sandusky; John Turk; Yan Xu
Journal:  FASEB J       Date:  2010-06-08       Impact factor: 5.191

Review 2.  E-cadherin's dark side: possible role in tumor progression.

Authors:  Fausto J Rodriguez; Laura J Lewis-Tuffin; Panos Z Anastasiadis
Journal:  Biochim Biophys Acta       Date:  2012-03-13

3.  EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells.

Authors:  Magdalena M Grabowska; Brindar Sandhu; Mark L Day
Journal:  Cell Signal       Date:  2011-10-14       Impact factor: 4.315

4.  Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis.

Authors:  C E Holmes; J E Levis; D L Ornstein
Journal:  Clin Exp Metastasis       Date:  2009-05-15       Impact factor: 5.150

Review 5.  Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.

Authors:  Xiaoqin Ye; Jerold Chun
Journal:  Trends Endocrinol Metab       Date:  2010-01       Impact factor: 12.015

Review 6.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 7.  Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.

Authors:  David N Brindley; Fang-Tsyr Lin; Gabor J Tigyi
Journal:  Biochim Biophys Acta       Date:  2012-08-29

Review 8.  Soluble E-cadherin: more than a symptom of disease.

Authors:  Magdalena M Grabowska; Mark L Day
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

Review 9.  Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.

Authors:  Maria V Barbolina; Rebecca J Burkhalter; M Sharon Stack
Journal:  Biochem J       Date:  2011-07-01       Impact factor: 3.857

10.  Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells.

Authors:  Yueying Liu; Rebecca Burkhalter; Jaime Symowicz; Kim Chaffin; Shawn Ellerbroek; M Sharon Stack
Journal:  J Oncol       Date:  2012-04-22       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.